REQUEST A DEMO
Total
USD $0.00
Search more companies

Wija Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Wija Pharma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Wija Pharma Sdn. Bhd. is a company based in Malaysia, with its head office in Kuching. It operates in the Pharmacies and Drug Stores sector. It was established on March 19, 2009. Wija Pharma Sdn. Bhd. currently employs 50 (2023) people. From the latest financial highlights, Wija Pharma Sdn. Bhd. reported a net sales revenue increase of 10.68% in 2021. Its total assets grew by 33.41% over the same period. The net profit margin of Wija Pharma Sdn. Bhd. decreased by 1.2% in 2021.

Headquarters
No. 19 Ground Floor, Kubah Ria Complex, Petra Jaya
Kuching; Sarawak; Postal Code: 93050

Contact Details: Purchase the Wija Pharma Sdn. Bhd. report to view the information.

Basic Information
Total Employees:
Purchase the Wija Pharma Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Wija Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Wija Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Wija Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
March 19, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Wija Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
10.68%
Total operating revenue
10.68%
Operating profit (EBIT)
-48.06%
EBITDA
-33.88%
Net Profit (Loss) for the Period
-61.3%
Total assets
33.41%
Total equity
40.22%
Operating Profit Margin (ROS)
-1.18%
Net Profit Margin
-1.2%
Return on Equity (ROE)
-29.7%
Debt to Equity Ratio
-32.16%
Quick Ratio
-0.18%
Cash Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?